LumiThera inks $5.5 mln Series B
LumiThera Inc., a medical device company focused on treating ocular disorders and diseases, has closed $5.5 million in Series B financing. WaterStone Capital led the round with participation from RPR Venture. In conjunction with the funding, WaterStone Capital's founding partner Yigang Yang will join the LumiThera board of directors.
31 October 2017•1 min read
